Overview
Plasma cell leukemia (PCL) is a type of blood cancer that affects a type of white blood cell called a plasma cell. It is caused by the accumulation of an abnormally large number of plasma cells usually found in the bone marrow or blood. PCL is an aggressive form of cancer and is usually resistant to chemotherapy, though bone marrow transplants and targeted therapy can be used to treat it. PCL is fairly rare, with only around 500 cases reported worldwide. However, it is an important cancer to understand, as it can occur in conjunction with other forms of blood cancer, and can be difficult to diagnose. Research into PCL is ongoing, and the prognosis is improving as treatments become more effective.
Research published in this journal
No peer-reviewed research on this exact topic has been published in Advances in Leukemia yet. Browse the journal →